ResMed Inc. logo

ResMed Inc. (RMD)

Market Open
5 Dec, 14:31
XWBO XWBO
219. 60
+3.8
+1.76%
- Market Cap
27.49 P/E Ratio
1.92% Div Yield
0 Volume
6.52 Eps
215.8
Previous Close
Day Range
219.6 221.9
Year Range
181.8 251.5
Want to track RMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days

Summary

RMD trading today higher at €219.6, an increase of 1.76% from yesterday's close, completing a monthly increase of 2.81% or €6. Over the past 12 months, RMD stock lost -1.3%.
RMD pays dividends to its shareholders, with the most recent payment made on Sep 18, 2025. The next announced payment will be in In 1 weeks on Dec 18, 2025 for a total of €0.6.
The last earnings report, released on Oct 23, 2025, exceeded the consensus estimates by 0.04%. On average, the company has fell short of earnings expectations by -0.79%, based on the last three reports. The next scheduled earnings report is due on Jan 22, 2026.
ResMed Inc. has completed 4 stock splits, with the recent split occurring on Aug 31, 2010.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).

RMD Chart

Should You Continue to Hold RMD Stock in Your Portfolio?

Should You Continue to Hold RMD Stock in Your Portfolio?

Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.

Zacks | 2 days ago
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may be a clearer winner.

Forbes | 1 week ago
ResMed: Safe Bet For A Recession Environment

ResMed: Safe Bet For A Recession Environment

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and significant cash reserves position it favorably for investors who want to protect their portfolio for a recession. RMD's operational efficiency and cash balance support continued dividend growth and potential buybacks.

Seekingalpha | 2 weeks ago

ResMed Inc. (RMD) FAQ

What is the stock price today?

The current price is €219.60.

On which exchange is it traded?

ResMed Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RMD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.92%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 2.7.

When is the next earnings date?

The next earnings report will release on Jan 22, 2026.

Has ResMed Inc. ever had a stock split?

ResMed Inc. had 4 splits and the recent split was on Aug 31, 2010.

ResMed Inc. Profile

- Industry
- Sector
Michael J. Farrell BE, MBA, SM CEO
XWBO Exchange
US7611521078 ISIN
US Country
9,980 Employees
13 Nov 2025 Last Dividend
31 Aug 2010 Last Split
2 Jun 1995 IPO Date

Overview

ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.

Products and Services

  • Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
  • Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
  • U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
  • Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.

Contact Information

Address: 9001 Spectrum Center Boulevard
Phone: 858 836 5000